Terrie Curran sold $956K of ARQT stock

Terrie Curran, Dir of Arcutis Biotherapeutics, Inc. (ARQT), sold 38,200 shares of ARQT stock worth $956K, per an SEC Form 4 filed Aug 28, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Aug 27, 2026, 1 day before it was made public.

ARQT has moved +2.7% since the trade date, from $24.87 to $25.55 (Nov 6, 2026 close).